EP4114934A1 - Variants de protéase vi à stabilité améliorée - Google Patents

Variants de protéase vi à stabilité améliorée

Info

Publication number
EP4114934A1
EP4114934A1 EP21708957.2A EP21708957A EP4114934A1 EP 4114934 A1 EP4114934 A1 EP 4114934A1 EP 21708957 A EP21708957 A EP 21708957A EP 4114934 A1 EP4114934 A1 EP 4114934A1
Authority
EP
European Patent Office
Prior art keywords
amino acid
protease
acid substitutions
correspond
positions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
EP21708957.2A
Other languages
German (de)
English (en)
Inventor
Christian DEGERING
Susanne Wieland
Nina Mussmann
Inken Prueser
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Henkel AG and Co KGaA
Original Assignee
Henkel AG and Co KGaA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henkel AG and Co KGaA filed Critical Henkel AG and Co KGaA
Publication of EP4114934A1 publication Critical patent/EP4114934A1/fr
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/52—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea
    • C12N9/54—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from bacteria or Archaea bacteria being Bacillus
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11D—DETERGENT COMPOSITIONS; USE OF SINGLE SUBSTANCES AS DETERGENTS; SOAP OR SOAP-MAKING; RESIN SOAPS; RECOVERY OF GLYCEROL
    • C11D3/00—Other compounding ingredients of detergent compositions covered in group C11D1/00
    • C11D3/16—Organic compounds
    • C11D3/38—Products with no well-defined composition, e.g. natural products
    • C11D3/386—Preparations containing enzymes, e.g. protease or amylase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21—Serine endopeptidases (3.4.21)
    • C12Y304/21062—Subtilisin (3.4.21.62)

Definitions

  • the invention is in the field of enzyme technology.
  • the invention relates to proteases from Bacillus pumilus, the amino acid sequence of which has been modified, in particular with regard to use in detergents and cleaning agents, in order to give them better storage stability, and the nucleic acids coding for them and their production.
  • the invention also relates to the uses of these proteases and processes in which they are used, as well as agents containing them, in particular detergents and cleaning agents.
  • proteases are among the technically most important enzymes of all. For detergents and cleaning agents, they are the longest established enzymes and are contained in practically all modern, high-performance washing and cleaning agents. They cause the degradation of protein-containing soiling on the items to be cleaned.
  • proteases of the subtilisin type (subtilases, subtilopeptidases, EC 3.4.21 .62) are particularly important, which are serine proteases due to the catalytically active amino acids. They act as non-specific endopeptidases and hydrolyze any acid amide bonds that are inside peptides or proteins. Their pH optimum is usually in the clearly alkaline range.
  • Subtilases Subtilisin-like Proteases
  • R. Siezen pages 75-95 in “Subtilisin enzymes”, edited by R. Bott and C. Betzel, New York, 1996.
  • Subtilases are natural formed by microorganisms. Among these, the subtilisins formed and secreted by Bacillus species should be mentioned as the most important group within the subtilases.
  • proteases of the subtilisin type preferably used in detergents and cleaning agents are the subtilisins BPN 'and Carlsberg, the protease PB92, the subtilisins 147 and 309, the protease from Bacillus lentus, in particular from Bacillus lentus DSM 5483, subtilisin DY and the the subtilases, but no longer the subtilisins in the narrower sense, the enzymes thermitase, proteinase K and the proteases TW3 and TW7, as well as variants of the proteases mentioned, which have a changed amino acid sequence compared to the starting protease.
  • Proteases are modified in a targeted or random manner by methods known from the prior art and thus optimized for use in detergents and cleaning agents, for example. These include point mutagenesis, deletion or insertion mutagenesis or fusion with other proteins or protein parts. For most of the proteases known from the prior art, correspondingly optimized variants are known.
  • protease from Bacillus pumilus intended for detergents and cleaning agents is disclosed.
  • only selected proteases are suitable for use in liquid surfactant-containing preparations.
  • Many proteases do not show sufficient catalytic properties in such preparations Power.
  • a high catalytic activity under conditions such as those presented during a wash cycle and a high storage stability are particularly desirable.
  • liquid formulations containing proteases and surfactants from the prior art have the disadvantage that the proteases contained do not have a satisfactory proteolytic activity or are not storage-stable under standard washing conditions (for example in a temperature range from 20 ° C. to 40 ° C.) the formulations therefore do not show optimal cleaning performance on protease-sensitive soils.
  • the invention therefore relates to a protease comprising an amino acid sequence which has at least 70% sequence identity with the amino acid sequence given in SEQ ID NO: 1 over its entire length and in each case, based on the numbering according to SEQ ID NO: 1, has:
  • amino acid substitutions in particular amino acid substitutions 9T, 130D / V, 133A, 144K,
  • the invention also relates to a method for producing a protease as defined above, comprising the substitution of amino acids in a starting protease which has at least 70% sequence identity to the amino acid sequence given in SEQ ID NO: 1 over its entire length (i) at the positions which correspond to positions 9, 130, 133, 144, 217, 252 and 271 in SEQ ID NO: 1, in such a way that the protease at positions amino acid substitutions, in particular amino acid substitutions 9T, 130D / V, 133A, 144K, 217M, 252T and 271 E, and (ii) at least one, preferably at least two, of the Positions which correspond to positions 6, 89, 131, 166, 189, 211 or 224 in SEQ ID NO: 1, have at least one further amino acid substitution, in particular selected from 6W / F, 89A / G, 131 H / Y / F, 166M / L / I, 189T / L / I, 211
  • a protease within the meaning of the present patent application therefore comprises both the protease as such and a protease produced using a method according to the invention. All statements on the protease therefore relate both to the protease as such and to the proteases produced by means of corresponding processes.
  • nucleic acids coding for these proteases relate to the nucleic acids coding for these proteases, proteases according to the invention or non-human host cells containing nucleic acids as well as agents comprising proteases according to the invention, in particular detergents and cleaning agents, washing and cleaning methods, and uses of the proteases according to the invention in washing or cleaning agents for removing protein-containing soiling .
  • At least one as used herein means one or more, i.e. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or more.
  • the present invention is based on the surprising finding of the inventors that amino acid substitutions at the positions described herein bring about an improved storage stability of this modified protease in detergents and cleaning agents.
  • the protease has substitutions at the positions which correspond to positions 6, 89, 131, 166, 189, 211 or 224, which are selected from the amino acid substitutions 6W / F, 89A / G, 131 H / Y / F, 166M / L / I, 189T / L / I, 211 N / Q and 224A / G, in particular from 6W, 89A, 131 H, 166M, 189T, 211 N and 224A.
  • the protease has corresponding substitutions in at least two of these positions.
  • substitutions can preferably be those in positions (i) 189 and 224, (ii) 166 and 189 or (iii) 166 and 211 and optionally at least one further position. These are preferably 189T, 224A, 166M and 211 N.
  • the protease is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoe hydrochloroe
  • amino acid substitutions particularly amino acid substitutions 9T, 130D / V, 133A, 144K, 217M, 252T and 271 E;
  • the protease is N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoethyl-N-(2-aminoethyl)-2-aminoe hydrochloroe
  • amino acid substitutions particularly amino acid substitutions 9T, 130D / V, 133A, 144K, 217M, 252T and 271 E;
  • 166, 189 and 224 correspond to amino acid substitutions 166M, 189T and 224A;
  • 89, 131, 189 and 224 correspond to amino acid substitutions 89A, 131H, 189T and 224A;
  • 89, 189 and 224 correspond to amino acid substitutions 89A, 189T and 224A;
  • (k) 89 and 211 correspond, amino acid substitutions 89A and 211 N;
  • (L) 89 and 224 correspond, amino acid substitutions 89A and 224A;
  • (p) 189 and 224 correspond, amino acid substitutions 189T and 224; on.
  • the proteases at positions corresponding to positions 9, 130, 133, 144, 217, 252 and 271 have the amino acid substitutions 9T, 130D, 133A, 144K, 217M, 252T and 271 E and at positions showing the positions
  • 166, 189 and 224 correspond to amino acid substitutions 166M, 189T and 224A;
  • 89, 131, 189 and 224 correspond to amino acid substitutions 89A, 131H, 189T and 224A;
  • 89, 189 and 224 correspond to amino acid substitutions 89A, 189T and 224A;
  • (f) 166 and 211 correspond, amino acid substitutions 166M and 211N; on.
  • the proteases at positions corresponding to positions 9, 130, 133, 144, 217, 252 and 271 have the amino acid substitutions 9T, 130V, 133A, 144K, 217M, 252T and 271 E as well as at positions corresponding to positions 89, 131,
  • 189 and 224 correspond to amino acid substitutions 89A, 131H, 189T and 224A.
  • the protease has amino acid substitutions at positions corresponding to positions 9, 130, 133, 144, 217, 252 and 271, in particular amino acid substitutions 9T, 130D / V, 133A, 144K, 217M, 252T and 271 E; and at one or more of the positions corresponding to positions 6, 89, 131, 166, 189, 211 or 224, at least one, for example 1, 2, 3, 4, 5 or 6, for example 1, 2, 3 or 4, further amino acid substitution (s), these being preferably selected from: 6W / F, 89A / G, 131 H / Y / F, 166M / L / I, 189T / L / I, 211 N / Q and 224A / G, more preferred from: 6W, 89A, 131 H, 166M, 189T, 211 N and 224A.
  • the rest of the sequence of the abovementioned proteases has sufficient sequence identity with SEQ ID NO: 1 that the overall sequence identity of the protease is at least 70%, preferably at least 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93% , 94%, 95%, 96% or 97%.
  • the remainder of the sequence of the protease ie the sequence with the exception of the positions mentioned herein, which may be mutated, is at least 80%, preferably at least 81%, 82%, 83%, 84%, 85%, 86% , 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% identical to the corresponding sequence of SEQ ID NO: 1.
  • the sequence of the protease, with the exception of the substitutions mentioned can correspond to the sequence of SEQ ID NO: 1.
  • the protease according to the invention has more than 70% and less than 100% sequence identity with SEQ ID NO: 1.
  • the protease according to the invention preferably has more than 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85 %, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96% or 97 %% and less than 100% sequence identity to SEQ ID NO: 1 on.
  • the sequence of the protease can correspond to the sequence of SEQ ID NO: 1.
  • the proteases of the invention have improved storage stability. They have an increased stability in detergents or cleaning agents compared to the wild-type enzyme and in particular also compared to the starting variant of the protease (SEQ ID NO: 2), in particular when stored for 3 or more days, 4 or more days, 7 or more Days, 10 or more days, 12 or more days, 14 or more days, 21 or more days, or 28 or more days. Such performance-enhanced proteases enable improved washing results on proteolytically sensitive soiling in different temperature ranges, in particular a temperature range from 20 ° C to 40 ° C.
  • the proteases according to the invention can, independently of or in addition to the increased storage stability, have increased catalytic activity in detergents or cleaning agents.
  • the proteases according to the invention can have a proteolytic activity that is at least 101%, preferably at least 101%, based on the wild type and / or an already performance-improved reference mutation variant of the protease (SEQ ID NO: 1 and / or SEQ ID NO: 2) 102%.
  • Such performance-enhanced proteases enable improved washing results on proteolytically sensitive soiling in different temperature ranges, in particular a temperature range from 20 ° C to 40 ° C.
  • proteases according to the invention have enzymatic activity, that is to say they are capable of hydrolyzing peptides and proteins, in particular in a washing or cleaning agent.
  • a protease according to the invention is therefore an enzyme which catalyzes the hydrolysis of amide / peptide bonds in protein / peptide substrates and is thereby able to cleave proteins or peptides.
  • a protease according to the invention is preferably a mature protease, i.e. the catalytically active molecule without signal and / or propeptide (s). Unless otherwise stated, the specified sequences also relate to mature (processed) enzymes.
  • the protease is a free enzyme. This means that the protease can act directly with all components of an agent and, if the agent is a liquid agent, that the protease is in direct contact with the agent's solvent (e.g. water).
  • an agent can contain proteases that form an interaction complex with other molecules or that contain an “envelope”.
  • a single or multiple protease molecules can be separated from the other components of the agent by a structure surrounding them.
  • a separating structure can arise from, but is not limited to, vesicles such as a micelle or a liposome.
  • the surrounding structure can also be a virus particle, a bacterial cell or a eukaryotic cell.
  • an agent can contain cells from Bacillus pumilus or Bacillus subtilus which express the proteases according to the invention, or cell culture supernatants of such cells.
  • the protease comprises an amino acid sequence which is at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77% of the total length of the amino acid sequence given in SEQ ID NO: 1 , 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91, 5%, 92%, 92.5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96%, 96.5% or 97% is identical, (where “at least” refers to each of the values mentioned) and in each case has the amino acid substitutions given above, based on the numbering according to SEQ ID NO: 1.
  • a protease has the specified substitutions means that it contains one (of the specified) substitution (s) at the respective position, ie at least the positions indicated are not otherwise mutated or deleted, for example by fragmentation of the protease.
  • the proteases described herein, with the exception of the explicitly mentioned substitutions have the sequence of SEQ ID NO: 1, ie, apart from the substituted positions, are 100% identical to the sequence according to SEQ ID NO: 1.
  • sequence comparison is based on the BLAST algorithm established in the prior art and usually used (cf. for example Altschul, SF, Gish, W., Miller, W., Myers, EW & Lipman, DJ (1990) "Basic local alignment search tool . "J. Mol. Biol. 215: 403-410, and Altschul, Stephan F., Thomas L. Madden, Alejandro A. Schaffer, Jinghui Zhang, Hheng Zhang, Webb Miller, and David J.
  • T-Coffee see, for example, Notredame et al . (2000): T-Coffee: A novel method for multiple sequence alignments. J. Mol. Biol. 302, 205-217) or programs based on these programs or algorithms. Sequence comparisons (alignments) are also possible with the computer program Vector NTI® Suite 10.3 (Invitrogen Corporation, 1600 Faraday Avenue, Carlsbad, California, USA) with the specified standard parameters, whose AlignX module for the sequence comparisons is based on ClustalW. Unless otherwise stated, the sequence identity given herein is determined using the BLAST algorithm.
  • Such a comparison also allows a statement to be made about the similarity of the compared sequences to one another. It is usually given in percent identity, that is to say the proportion of identical nucleotides or amino acid residues in the same positions or in positions corresponding to one another in an alignment.
  • the broader term of homology includes conserved amino acid exchanges in the case of amino acid sequences, i.e. amino acids with similar chemical activity, since these usually exert similar chemical activities within the protein. Therefore, the similarity of the compared sequences can also be given as percent homology or percent similarity. Identity and / or homology information can be made over entire polypeptides or genes or only over individual areas. Homologous or identical regions of different nucleic acid or amino acid sequences are therefore defined by matches in the sequences.
  • Such areas often have identical functions. They can be small and only a few nucleotides or include amino acids. Such small areas often have essential functions for the overall activity of the protein. It can therefore be useful to refer to sequence correspondences only to individual, possibly small areas. Unless otherwise stated, identity or homology details in the present application refer to the total length of the nucleic acid or amino acid sequence specified in each case.
  • an amino acid position corresponds to a numerically designated position in SEQ ID NO: 1 means that the corresponding position is assigned to the numerically designated position in SEQ ID NO: 1 in an alignment as defined above.
  • the protease is characterized in that its cleaning performance (after storage, for example over 4 weeks) is not significantly reduced compared to that of a protease which comprises an amino acid sequence which corresponds to the amino acid sequence given in SEQ ID NO: 2, ie has at least 80% of the reference washing performance, preferably at least 100%, more preferably at least 110% or more.
  • the cleaning performance can be determined in a washing system that contains a detergent in a dosage between 4.5 and 7.0 grams per liter of washing liquor as well as the protease, with the proteases to be compared being used in the same concentration (based on active protein) and the cleaning performance opposite Soiling on cotton is determined by measuring the degree of cleaning of the washed textiles.
  • the washing process can take place for 60 minutes at a temperature of 40 ° C and the water can have a water hardness between 15.5 ° dH and 16.5 ° dH (German hardness).
  • the concentration of the protease in the detergent intended for this washing system is 0.001 to 0.1% by weight, preferably 0.01 to 0.06% by weight, based on active, purified protein.
  • a liquid reference detergent for such a washing system can be composed as follows (all data in percent by weight): 4.4% alkylbenzenesulfonic acid, 5.6% other anionic surfactants, 2.4% C12-C18 Na salts of fatty acids (soaps) , 4.4% non-ionic surfactants, 0.2% phosphonates, 1.4% citric acid, 0.95% NaOH, 0.01% defoamer, 2% glycerine, 0.08% preservatives, 1% ethanol, the remainder demineralized Water.
  • the dosage of the liquid detergent is preferably between 4.5 and 6.0 grams per liter of wash liquor, for example 4.7, 4.9 or 5.9 grams per liter of wash liquor. Washing is preferably carried out in a pH range between pH 7 and pH 10.5, preferably between pH 7.5 and pH 8.5.
  • the cleaning performance is determined, for example, at 20 ° C. or 40 ° C. using a liquid detergent as indicated above, the washing process preferably taking place for 60 minutes at 600 rpm.
  • the degree of whiteness ie the lightening of the soiling, as a measure of the cleaning performance, is determined using optical measuring methods, preferably photometrically.
  • a suitable device for this is, for example, the Minolta CM508d spectrometer.
  • the devices used for the measurement are usually calibrated beforehand with a white standard, preferably a supplied white standard.
  • the use of the respective protease for the same level of activity ensures that the respective enzymatic properties, e.g. the cleaning performance on certain soiling, are compared even if there is a gap in the ratio of active substance to total protein (the values of the specific activity). In general, a low specific activity can be compensated for by adding a larger amount of protein.
  • the protease activity can be determined via the release of the chromophore para-nitroaniline (pNA) from the substrate suc-L-Ala-L-Ala-L-Pro-L-Phe-p-nitroanilide (AAPF).
  • pNA chromophore para-nitroaniline
  • the protease cleaves the substrate and releases pNA.
  • the release of the pNA causes an increase in the extinction at 410 nm, the course of which over time is a measure of the enzymatic activity (cf.
  • the measurement is carried out at a temperature of 25 ° C., at pH 8.6, and a wavelength of 410 nm.
  • the measurement time is 5 minutes and the measurement interval is 20 s to 60 s.
  • the protease activity is usually specified in protease units (PU) . Suitable protease activities are, for example, 2.25, 5 or 10 PU per ml of wash liquor. However, the protease activity is not zero.
  • An alternative test for determining the proteolytic activity of the proteases according to the invention is an optical measuring method, preferably a photometric method.
  • the test suitable for this comprises the protease-dependent cleavage of the substrate protein casein. This is split by the protease into a large number of smaller partial products. All of these partial products have an increased absorption at 290 nm compared to non-split casein, this increased absorption being determined using a photometer and thus a conclusion about the enzymatic activity of the protease can be drawn.
  • the protein concentration can be determined using known methods, for example the BCA method (bicinchoninic acid; 2,2'-bichinolyl-4,4'-dicarboxylic acid) or the biuret method (AG Gornall, CS Bardawill and MM David, J. Biol. Chem., 177 (1948), pp. 751-766).
  • the active protein concentration can be determined by titrating the active centers using a suitable irreversible inhibitor and determining the residual activity (cf. M. Bender et al., J. Am. Chem. Soc. 88, 24 (1966), p. 5890 -5913).
  • proteases according to the invention can have further amino acid changes, in particular amino acid substitutions, insertions or deletions.
  • Such proteases are further developed, for example, by targeted genetic modification, ie by mutagenesis processes, and optimized for specific purposes or with regard to special properties (for example with regard to their catalytic activity, stability, etc.).
  • nucleic acids according to the invention can be introduced into recombination batches and thus used to generate completely new proteases or other polypeptides.
  • the aim is to introduce targeted mutations such as substitutions, insertions or deletions into the known molecules, for example in order to improve the cleaning performance of enzymes according to the invention.
  • the surface charges and / or the isoelectric point of the molecules and thereby their interactions with the substrate can be changed.
  • the net charge of the enzymes can be changed in order to influence the substrate binding, especially for use in detergents and cleaning agents.
  • one or more corresponding mutations can increase the stability or catalytic activity of the protease and thereby improve its cleaning performance.
  • Advantageous properties of individual mutations, e.g. individual substitutions can complement each other.
  • a protease that has already been optimized with regard to certain properties, for example with regard to its stability during storage, can therefore be further developed within the scope of the invention.
  • amino acid substitutions first, the naturally present amino acid is designated in the form of the internationally common single-letter code, then the associated sequence position and finally the inserted amino acid. Multiple or alternative exchanges within the same polypeptide chain are separated from one another by slashes. “130D / V” thus means that position 130 has mutated to D or V. In the case of insertions, additional amino acids are named after the sequence position. In the case of deletions, the missing amino acid is replaced by a symbol, for example an asterisk or a dash, or a D is given in front of the corresponding position.
  • P9T describes the substitution of proline at position 9 by threonine
  • P9TH the insertion of histidine after the amino acid threonine at position 9
  • P9 * or DR9 the deletion of proline at position 9.
  • the invention therefore also provides a protease which is characterized in that it can be obtained from a protease as described above as the starting molecule by single or multiple conservative amino acid substitutions, the protease being those described above in the number according to SEQ ID NO: 1 Has amino acid substitutions.
  • conservative amino acid substitution means the exchange (substitution) of one Amino acid residue for another amino acid residue, this exchange not leading to a change in polarity or charge at the position of the exchanged amino acid, eg the exchange of a non-polar amino acid residue for another non-polar amino acid residue.
  • the protease is characterized in that it can be obtained from a protease according to the invention as the starting molecule by fragmentation, deletion, insertion or substitution mutagenesis and comprises an amino acid sequence that is at least 200, 210, 220, 230, 240, 250, 260, 261, 262, 263, 264, 265, 266, 267, 268, 269, 270, 271, 272, 273 or 274 contiguous amino acids coincide with the starting molecule, the amino acid substitutions described above, ie the substitutions 9T, 130D / V, 133A, 144K, 217M, 252T and 271 E at the positions corresponding to positions 9, 130, 133, 144, 217, 252 and 271; and a further amino acid substitution at at least one, preferably at least two, of the positions which correspond to positions 6, 89, 131, 166, 189, 211 or 224 are still present.
  • the enzymes retain their proteolytic activity even after the mutagenesis, i.e. their proteolytic activity corresponds at least to that of the starting enzyme, i.e. in a preferred embodiment the proteolytic activity is at least 80%, preferably at least 90% of the activity of the starting enzyme. Further substitutions can also have advantageous effects. Both single and several connected amino acids can be exchanged for other amino acids.
  • the further amino acid positions are defined here by an alignment of the amino acid sequence of a protease according to the invention with the amino acid sequence of the protease from Bacillus pumilus, as indicated in SEQ ID NO: 1. Furthermore, the allocation of the positions is based on the mature (mature) protein. This assignment is also to be used in particular if the amino acid sequence of a protease according to the invention comprises a higher number of amino acid residues than the protease from Bacillus pumilus according to SEQ ID NO: 1. Starting from the positions mentioned in the amino acid sequence of the protease from Bacillus pumilus, the change positions in a protease according to the invention are those which are assigned to precisely these positions in an alignment.
  • Advantageous positions for sequence changes, in particular substitutions, of the protease from Bacillus pumilus which are preferably of importance when transferred to homologous positions of the proteases according to the invention and give the protease advantageous functional properties, are accordingly the positions which correspond to the positions described herein in an alignment, ie in the number according to SEQ ID NO: 1.
  • the following amino acid residues are located at the positions mentioned in the wild-type molecule of the protease from Bacillus pumilus: P9, N130, T133, N144, Y217, N252 and Q271 as well as Y6, S89, G131, G166, S189, S211 and S224.
  • a further confirmation of the correct assignment of the amino acids to be changed can be provided by comparison tests, according to which the two positions assigned to one another on the basis of an alignment are changed in the same way in the two compared proteases and it is observed whether in both the enzymatic activity is changed in the same way.
  • an amino acid exchange in a certain position of the protease from Bacillus pumilus according to SEQ ID NO: 1 is accompanied by a change in an enzymatic parameter, for example with an increase in the K M value, and a corresponding change in the enzymatic parameter, for example also a
  • An increase in the K M value observed in a protease variant according to the invention, the amino acid exchange of which was achieved by the same introduced amino acid, is a confirmation of the correct assignment.
  • a method according to the invention further comprises one or more of the following method steps: a) Introducing a single or multiple conservative amino acid substitution into the protease, the protease having the substitutions 9T, 130D / V, 133A, 144K, 217M, 252T and 271 E on the Positions corresponding to positions 9, 130, 133, 144, 217, 252 and 271; as well as at least one further amino acid substitution at at least one or at least two of the positions corresponding to positions 6, 89, 131, 166, 189, 211 or 224; b) Altering the amino acid sequence by fragmentation, deletion, insertion or substitution mutagenesis in such a way that the protease comprises an amino acid sequence that is at least 200, 210, 220, 230, 240, 250, 260, 261, 262, 263, 264, 265, 266, 267, 268, 2
  • the protease or the protease produced with a method according to the invention is still at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91, 5%, 92%, 92 , 5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96%, 96.5% or 97%, identical to the amino acid sequence given in SEQ ID NO: 1 over their total length.
  • the protease or the protease produced using a method according to the invention is still at least 70%, 71%, 72%, 73%, 74%, 75%, 76%, 77%, 78%, 79%, 80%, 81 %, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 90.5%, 91%, 91, 5%, 92%, 92.5%, 93%, 93.5%, 94%, 94.5%, 95%, 95.5%, 96%, 96.5%, 97%, 97.5%, 98%, 98.5 or 99% identical to the amino acid sequences given in SEQ ID NO: 2 over their entire length.
  • the protease or the protease produced by a method according to the invention has the amino acid substitutions 9T, 130D / V, 133A, 144K, 217M, 252T and 271 E at the positions which correspond to positions 9, 130, 133, 144, 252 and 271; and at least one, preferably at least two, further amino acid substitution (s) in at least one of the positions corresponding to positions 6, 89, 131, 166, 189, 211 or 224, each based on the numbering according to SEQ ID NO: 1 .
  • Examples include the following amino acid substitution variants: P9T, N130D, T133A, N144K, Y217M, N252T and Q271 E combined with one of (i) G166M and S189T; (ii) G166M, S189T and S224A (iii) S89A, G131 H and S189T; (iv) S89A and S189T; (v) Y6W, S189T and S224A; or (vi) G166M and S211 N, or P9T, N130V, T133A, N144K, Y217M, N252T and Q271 E combined with S89A, G131 H and S189T, whereby the numbering is based on the numbering according to SEQ ID NO: 1 and the variants described in the examples.
  • the invention also relates to a protease described above which is additionally stabilized, in particular by one or more mutations, for example substitutions, or by coupling to a polymer.
  • An increase in the stability during storage and / or during use, for example during the washing process, means that the enzymatic activity lasts longer and thus the cleaning performance is improved.
  • all stabilization options described and / or expedient in the prior art come into consideration. Stabilizations that are achieved via mutations of the enzyme itself are preferred, since such stabilizations do not require any further work steps following the recovery of the enzyme. Examples of sequence changes suitable for this are mentioned above. Further suitable sequence changes are known from the prior art.
  • Changing the binding of metal ions, in particular the calcium binding sites for example by exchanging one or more of the amino acid (s) involved in calcium binding for one or more negatively charged amino acids and / or by introducing sequence changes in at least one of the consequences of the two amino acids arginine / glycine; Protection against the influence of denaturing agents such as surfactants through mutations that cause a change in the amino acid sequence on or on the surface of the protein; Replacement of amino acids that are close to the N-terminus for those that presumably come into contact with the rest of the molecule via non-covalent interactions and thus contribute to maintaining the globular structure.
  • Preferred embodiments are those in which the enzyme is stabilized in several ways, since several stabilizing mutations act additively or synergistically.
  • Another object of the invention is a protease as described above, which is characterized in that it has at least one chemical modification.
  • a protease with such a change is called a derivative, i.e. the protease is derivatized.
  • derivatives are accordingly understood to mean those proteins whose pure amino acid chain has been chemically modified.
  • derivatizations can take place, for example, in vivo by the host cell which expresses the protein.
  • couplings of low molecular weight compounds such as lipids or oligosaccharides should be particularly emphasized.
  • derivatizations can also be carried out in vitro, for example by chemically converting a side chain of an amino acid or by covalently binding another compound to the protein.
  • Such a different compound can also be a further protein which is bound to a protein according to the invention, for example via bifunctional chemical compounds.
  • derivatization is to be understood as the covalent bond to a macromolecular carrier, or also a non-covalent inclusion in suitable macromolecular cage structures.
  • Derivatizations can, for example, influence the substrate specificity or the strength of the binding to the substrate or cause a temporary blocking of the enzymatic activity if the coupled substance is an inhibitor. This can be useful for the period of storage, for example.
  • Such modifications can also affect the stability or the enzymatic activity. They can also serve to reduce the allergenicity and / or immunogenicity of the protein and thus, for example, to increase its skin tolerance.
  • couplings with macromolecular compounds for example polyethylene glycol, can improve the protein with regard to stability and / or skin tolerance.
  • derivatives of a protein according to the invention can also be understood to mean preparations of these proteins.
  • a protein can be combined with various other substances, for example from the culture of the producing microorganisms.
  • a protein can also have been specifically mixed with other substances, for example to increase its storage stability.
  • According to the invention are therefore also all preparations of a protein according to the invention. This is also independent of whether it actually displays this enzymatic activity in a particular preparation or not. This is because it may be desired that it has little or no activity during storage and that it only develops its enzymatic function at the time of use. This can be controlled, for example, via corresponding accompanying substances.
  • the joint preparation of proteases with specific inhibitors is possible in this regard.
  • proteases or protease variants and / or derivatives described above those whose storage stability corresponds at least to the protease according to SEQ ID NO: 2 or the variants tested in the examples and / or whose cleaning performance corresponds to at least the protease are particularly preferred in the context of the present invention according to SEQ ID NO: 2 or the variants tested in the examples, the cleaning performance being determined in a washing system as described above.
  • Another object of the invention is a nucleic acid which codes for a protease according to the invention, and a vector containing such a nucleic acid, in particular a cloning vector or an expression vector.
  • RNA molecules can be DNA or RNA molecules. They can be present as a single strand, as a single strand complementary to this single strand, or as a double strand. In the case of DNA molecules in particular, the sequences of both complementary strands must be taken into account in all three possible reading frames. It should also be taken into account that different codons, ie base triplets, can code for the same amino acids, so that a certain amino acid sequence can be coded by several different nucleic acids. Because of this degeneracy of the genetic code, all nucleic acid sequences are included in this subject matter of the invention which can code for one of the proteases described above.
  • nucleic acids according to the invention are able to determine these nucleic acid sequences unequivocally because, despite the degeneracy of the genetic code, defined amino acids have to be assigned to individual codons. The person skilled in the art can therefore easily determine nucleic acids coding for this amino acid sequence on the basis of an amino acid sequence. Furthermore, in the case of nucleic acids according to the invention, one or more codons can be replaced by synonymous codons. This aspect relates in particular to the heterologous expression of the enzymes according to the invention. Every organism, for example a host cell of a production strain, has a specific codon usage. Codon usage is understood to mean the translation of the genetic code into amino acids by the respective organism.
  • Bottlenecks in protein biosynthesis can occur if the codons on the nucleic acid are compared to a comparatively small number of loaded tRNA molecules in the organism. Although coding for the same amino acid, this leads to a codon being translated less efficiently in the organism than a synonymous codon that is for the same Amino acid encoded. Due to the presence of a higher number of tRNA molecules for the synonymous codon, this can be translated more efficiently in the organism.
  • a person skilled in the art is able to use known DNA and / or amino acid sequences to use known DNA and / or amino acid sequences to identify the corresponding nucleic acids up to complete genes using methods that are generally known nowadays, such as chemical synthesis or the polymerase chain reaction (PCR) in conjunction with standard molecular biological and / or protein chemical methods to manufacture.
  • PCR polymerase chain reaction
  • Such methods are for example from Sambrook, J., Fritsch, E.F. and Maniatis, T. 2001. Molecular cloning: a laboratory manual, 3rd Edition Cold Spring Laboratory Press.
  • vectors are understood to mean elements consisting of nucleic acids which contain a nucleic acid according to the invention as the characterizing nucleic acid region. They are able to establish this as a stable genetic element in a species or a cell line over several generations or cell divisions.
  • Vectors are special plasmids, i.e. circular genetic elements, especially when used in bacteria.
  • a nucleic acid according to the invention is cloned into a vector.
  • the vectors include, for example, those whose origin is bacterial plasmids, viruses or bacteriophages, or predominantly synthetic vectors or plasmids with elements of various origins. With the other genetic elements present in each case, vectors are able to establish themselves as stable units in the host cells concerned over several generations. They can exist extrachromosomally as separate units or can be integrated into a chromosome or chromosomal DNA.
  • Expression vectors comprise nucleic acid sequences which enable them to replicate in the host cells containing them, preferably microorganisms, particularly preferably bacteria, and to express a nucleic acid contained there.
  • the expression is influenced in particular by the promoter or promoters that regulate transcription.
  • expression can take place through the natural promoter originally located in front of the nucleic acid to be expressed, but also through a promoter of the word cell provided on the expression vector or also through a modified or a completely different promoter from another organism or another word cell.
  • at least one promoter is made available for the expression of a nucleic acid according to the invention and used for its expression.
  • Expression vectors can also be regulatable, for example by changing the cultivation conditions or when a certain cell density of the word cells they contain has been reached or by adding certain substances, in particular activators of gene expression.
  • An example of such a substance is the galactose derivative isopropyl- ⁇ -D-thiogalactopyranoside (IPTG), which is used as an activator of the bacterial lactose operon (lac operon).
  • IPTG galactose derivative isopropyl- ⁇ -D-thiogalactopyranoside
  • lac operon lac operon
  • the invention also relates to a non-human host cell which contains a nucleic acid according to the invention or a vector according to the invention, or which contains a protease according to the invention, in particular one which secretes the protease into the medium surrounding the host cell.
  • a nucleic acid according to the invention or a vector according to the invention is preferably transformed into a microorganism which then represents a host cell according to the invention.
  • individual components, ie nucleic acid parts or fragments of a nucleic acid according to the invention can also be introduced into a host cell in such a way that the host cell then resulting contains a nucleic acid according to the invention or a vector according to the invention.
  • This procedure is particularly suitable when the host cell already contains one or more components of a nucleic acid according to the invention or a vector according to the invention and the further components are then supplemented accordingly.
  • Methods for transforming cells are established in the prior art and are sufficiently known to the person skilled in the art. In principle, all cells, that is, prokaryotic or eukaryotic cells, are suitable as host cells. Preference is given to those host cells which can be manipulated in a genetically advantageous manner, for example with regard to the transformation with the nucleic acid or the vector and its stable establishment, for example unicellular fungi or bacteria. Furthermore, preferred host cells are characterized by good microbiological and biotechnological manageability.
  • Preferred host cells according to the invention secrete the (transgenically) expressed protein into the medium surrounding the host cells.
  • the proteases can be modified by the cells producing them after they have been produced, for example by attaching sugar molecules, formylations, aminations, etc. Such post-translational modifications can functionally influence the protease.
  • Further preferred embodiments are those host cells whose activity can be regulated on the basis of genetic regulatory elements which are provided, for example, on the vector, but can also be present in these cells from the outset. For example, by the controlled addition of chemical compounds that serve as activators, by changing the cultivation conditions or when a certain cell density is reached, these can be stimulated to express. This enables the proteins according to the invention to be produced economically.
  • An example of such a connection is IPTG as described above.
  • Preferred host cells are prokaryotic or bacterial cells. Bacteria are characterized by short generation times and low demands on the cultivation conditions. In this way, inexpensive cultivation processes or manufacturing processes can be established. In addition, the specialist in bacteria in fermentation technology has a wealth of experience. For a special production you can choose from the most varied, in individual cases Reasons to be determined experimentally such as nutrient sources, product formation rate, time required, etc., gram-negative or gram-positive bacteria must be suitable.
  • Gram-negative bacteria such as Escherichia coli
  • a large number of proteins are secreted into the periplasmic space, i.e. into the compartment between the two membranes enclosing the cells.
  • Gram-negative bacteria can also be designed in such a way that they channel the expressed proteins not only into the periplasmic space, but also into the medium surrounding the bacterium.
  • Gram-positive bacteria such as Bacilli or Actinomycetes or other representatives of the Actinomycetales, on the other hand, do not have an outer membrane, so that secreted proteins are immediately released into the medium surrounding the bacteria, usually the nutrient medium, from which the expressed proteins can be purified. They can be isolated directly from the medium or processed further.
  • Gram-positive bacteria are related or identical to most organisms of origin for technically important enzymes and usually form comparable enzymes themselves, so that they have a similar codon usage and their protein synthesis apparatus is naturally designed accordingly.
  • Host cells according to the invention can be changed with regard to their requirements for the culture conditions, have different or additional selection markers or also express other or additional proteins.
  • these host cells can also be those which transgenically express several proteins or enzymes.
  • the present invention can in principle be applied to all microorganisms, in particular to all fermentable microorganisms, particularly preferably to those of the genus Bacillus, and leads to the fact that proteins according to the invention can be produced by using such microorganisms. Such microorganisms then represent host cells within the meaning of the invention.
  • the host cell is characterized in that it is a bacterium, preferably one selected from the group of the genera Escherichia, Klebsiella, Bacillus, Staphylococcus, Corynebacterium, Arthrobacter, Streptomyces, Stenotrophomonas and Pseudomonas, more preferably one which is selected from the group of Escherichia coli, Klebsiella planticola, Bacillus licheniformis, Bacillus lentus, Bacillus amyloliquefaciens, Bacillus subtilis, Bacillus alcalophilus, Bacillus globigii, Bacillus gibsonii, Bacillus clausumacterii, Bacillus halodurium, Bacillus paphumlocus Clausillus, Bacillus haloduros Arthrobacter oxidans, Streptomyces lividans, Streptomyces coelicolor and Stenotrophomona
  • the host cell can, however, also be a eukaryotic cell, which is characterized in that it has a cell nucleus.
  • the invention therefore also provides a host cell which is characterized in that it has a cell nucleus.
  • prokaryotic Cells are eukaryotic cells able to post-translationally modify the protein produced. Examples are fungi such as Actinomycetes or yeasts such as Saccharomyces or Kluyveromyces. This can be particularly advantageous, for example, if the proteins are to undergo specific modifications in connection with their synthesis, which make such systems possible.
  • the modifications carried out by eukaryotic systems, particularly in connection with protein synthesis include, for example, the binding of low molecular weight compounds such as membrane anchors or oligosaccharides. Such oligosaccharide modifications can be desirable, for example, to reduce the allergenicity of an expressed protein. Coexpression with the enzymes naturally formed by such cells, such as cellulases, can also be advantageous. Furthermore, for example, thermophilic fungal expression systems can be particularly suitable for expressing temperature-resistant proteins or variants.
  • the host cells according to the invention are cultivated and fermented in the usual way, for example in discontinuous or continuous systems.
  • a suitable nutrient medium is inoculated with the host cells and the product is harvested from the medium after a period of time to be determined experimentally.
  • Continuous fermentations are characterized by the achievement of a steady state in which cells partially die off over a comparatively long period of time but also grow back and at the same time the protein formed can be removed from the medium.
  • Host cells according to the invention are preferably used to produce proteases according to the invention.
  • the invention therefore also relates to a method for producing a protease comprising a) culturing a host cell according to the invention, and b) isolating the protease from the culture medium or from the host cell.
  • This subject matter of the invention preferably comprises fermentation processes. Fermentation processes are known per se from the prior art and represent the actual large-scale production step, usually followed by a suitable purification method for the product produced, for example the proteases according to the invention. All fermentation processes which are based on a corresponding process for producing a protease according to the invention represent embodiments of this subject matter of the invention.
  • Fermentation processes which are characterized in that the fermentation is carried out using a feed strategy are particularly suitable.
  • the media components that are consumed by the ongoing cultivation are fed.
  • considerable increases can be achieved both in the cell density and in the cell mass or dry mass and / or in particular in the activity of the protease of interest will.
  • the fermentation can also be designed in such a way that undesired metabolic products are filtered out or neutralized by adding buffers or appropriate counterions.
  • the protease produced can be harvested from the fermentation medium. Such a fermentation process is preferred over isolation of the protease from the host cell, ie product processing from the cell mass (dry matter), but requires the provision of suitable word cells or one or more suitable secretion markers or mechanisms and / or transport systems so that the word cells can Secrete protease into the fermentation medium.
  • the protease can be isolated from the cell, i.e. it can be purified from the cell mass, for example by precipitation with ammonium sulfate or ethanol, or by chromatographic purification.
  • Another object of the invention is an agent which is characterized in that it contains a protease according to the invention as described above.
  • the agent is preferably a washing or cleaning agent.
  • This subject matter of the invention includes all conceivable types of detergents or cleaning agents, both concentrates and agents to be used undiluted, for use on a commercial scale, in the washing machine or for hand washing or cleaning.
  • detergents for textiles, carpets, or natural fibers, for which the term detergent is used.
  • the detergents and cleaning agents within the scope of the invention also include washing aids that are added to the actual washing agent during manual or machine laundry in order to achieve a further effect.
  • laundry detergents and cleaning agents in the context of the invention also include textile pretreatment and aftertreatment agents, i.e. those agents with which the item of laundry is brought into contact before the actual washing, for example to loosen stubborn dirt, and also those agents that are in one of the actual Textile washing, the subsequent step, give the laundry further desirable properties such as a pleasant grip, crease resistance or low static charge.
  • the last-mentioned agents include fabric softeners.
  • the detergents or cleaning agents according to the invention which can be present as pulverulent solids, in compacted particle form, as homogeneous solutions or suspensions, can contain, in addition to a protease according to the invention, all known ingredients that are customary in such agents, with at least one further ingredient preferably being present in the agent .
  • the agents according to the invention can in particular contain surfactants, builders, peroxygen compounds or bleach activators. Furthermore, they can contain water-miscible organic solvents, further enzymes, sequestering agents, electrolytes, pH regulators and / or further auxiliaries such as optical brighteners, graying inhibitors, foam regulators and colorants and fragrances and combinations thereof.
  • a combination of a protease according to the invention with one or more further ingredient (s) of the agent is advantageous, since such an agent in preferred embodiments according to the invention has an improved cleaning performance due to the resulting synergies.
  • Such a synergism can be achieved in particular by combining a protease according to the invention with a surfactant and / or a builder and / or a peroxygen compound and / or a bleach activator.
  • the agent according to the invention cannot contain any boric acid.
  • An agent according to the invention advantageously contains the protease in an amount from 2 pg to 20 mg, preferably from 5 pg to 17.5 mg, particularly preferably from 20 pg to 15 mg and very particularly preferably from 50 pg to 10 mg per g of the agent.
  • the concentration of the protease (active enzyme) described herein in the agent is> 0 to 1% by weight, preferably 0.0001 or 0.001 to 0.1% by weight, based on the total weight of the agent or the composition.
  • the protease contained in the agent and / or other ingredients of the agent can be coated with a substance which is impermeable to the enzyme at room temperature or in the absence of water and which becomes permeable to the enzyme under the conditions in which the agent is used.
  • Such an embodiment of the invention is thus characterized in that the protease is coated with a substance which is impermeable to the protease at room temperature or in the absence of water.
  • the washing or cleaning agent itself can also be packaged in a container, preferably an air-permeable container, from which it is released shortly before use or during the washing process.
  • the agent is characterized in that it (a) is in solid form, in particular as a free-flowing powder with a bulk density of 300 g / l to 1200 g / l, in particular 500 g / l to 900 g / l, or (b) is present in pasty or liquid form, and / or
  • inventions of the present invention include all solid, powdery, liquid, gel-like or pasty dosage forms of agents according to the invention, which can optionally also consist of several phases and can be in compressed or uncompressed form.
  • the agent can be in the form of a free-flowing powder, in particular with a bulk density of 300 g / l to 1200 g / l, in particular 500 g / l to 900 g / l or 600 g / l to 850 g / l.
  • the solid dosage forms of the agent also include extrudates, granules, tablets or pouches.
  • the agent can also be liquid, gel-like or pasty, for example in the form of a non-aqueous liquid detergent or a non-aqueous paste or in the form of an aqueous liquid detergent or a water-containing paste. Liquid funds are generally preferred.
  • the agent can be in the form of a one-component system. Such means consist of a phase. Alternatively, a remedy can also consist of several phases. Such a means is therefore divided into several components.
  • Washing or cleaning agents according to the invention can exclusively contain a protease. Alternatively, they can also contain further hydrolytic enzymes or other enzymes in an appropriate concentration for the effectiveness of the agent. Agents which further comprise one or more further enzymes thus represent a further embodiment of the invention.
  • enzymes that can preferably be used are all enzymes which can develop a catalytic activity in the agent according to the invention, in particular a lipase, amylase, cellulase, hemicellulase, mannanase, tannase, xylanase, xanthanase, xyloglucanase, ⁇ -glucosidase, pectinase, carrageenase, perhydrolase, Oxidase, oxidoreductase or other proteases - distinguishable from the proteases according to the invention - and mixtures thereof.
  • Further enzymes are advantageously contained in the agent in an amount of 1 ⁇ 10 -8 to 5 percent by weight based on active protein.
  • Each further enzyme is increasingly preferred in an amount of 1 ⁇ 10 -7 to 3% by weight, from 0.00001 to 1% by weight, from 0.00005 to 0.5% by weight, from 0.0001 up to 0.1% by weight and particularly preferably from 0.0001 to 0.05% by weight in agents according to the invention, based on active protein.
  • the enzymes particularly preferably show synergistic cleaning performance with respect to certain soiling or stains, ie the enzymes contained in the agent composition mutually support one another in their cleaning performance.
  • Such a synergism is very particularly preferably present between the protease contained according to the invention and a further enzyme of an agent according to the invention, including in particular between said protease and an amylase and / or a lipase and / or a mannanase and / or a cellulase and / or a pectinase .
  • Synergistic effects can occur not only between different enzymes, but also occur between one or more enzymes and other ingredients of the agent according to the invention.
  • the enzymes to be used can also be packaged together with accompanying substances, for example from fermentation.
  • the enzymes are preferably used as liquid enzyme formulation (s).
  • the enzymes are not provided in the form of the pure protein, but rather in the form of stabilized, storable and transportable preparations.
  • These ready-made preparations include, for example, the solid preparations obtained by granulation, extrusion or lyophilization or, in particular in the case of liquid or gel-like agents, solutions of the enzymes, advantageously as concentrated as possible, with little water and / or with stabilizers or other auxiliaries.
  • the enzymes can be encapsulated both for the solid and for the liquid dosage form, for example by spray drying or extrusion of the enzyme solution together with a preferably natural polymer or in the form of capsules, for example those in which the enzymes are enclosed as in a solidified gel or in those of the core-shell type, in which an enzyme-containing core is coated with a protective layer impermeable to water, air and / or chemicals.
  • Additional active ingredients for example stabilizers, emulsifiers, pigments, bleaches or dyes, can also be applied in superimposed layers.
  • Such capsules are applied by methods known per se, for example by pouring or rolling granulation or in fluid-bed processes. Such granules are advantageously low in dust, for example due to the application of polymeric film formers, and due to the coating are stable in storage.
  • water-soluble films such as those used, for example, in the formulation of detergents and cleaning agents in unit dose form.
  • Such a film enables the enzymes to be released after contact with water.
  • water soluble refers to a film structure that is preferably completely water soluble.
  • Such a film preferably consists of (completely or partially hydrolyzed) polyvinyl alcohol (PVA).
  • Another subject matter of the invention is a method for cleaning textiles or hard surfaces, which is characterized in that an agent according to the invention is used in at least one method step, or that a protease according to the invention becomes catalytically active in at least one method step, in particular such that the protease in one Amount from 40 pg to 4 g, preferably from 50 pg to 3 g, particularly preferably from 100 pg to 2 g and very particularly preferably from 200 pg to 1 g or in the concentrations described herein.
  • the method described above is characterized in that the protease is at a temperature of 0 ° C to 100 ° C, preferably 0 ° C to 60 ° C, more preferably 20 ° C to 40 ° C and most preferably at 25 ° C is used.
  • Processes for cleaning textiles are generally characterized in that various active cleaning substances are applied to the items to be cleaned in several process steps and washed off after the exposure time, or that the items to be cleaned are treated in some other way with a detergent or a solution or dilution of this agent.
  • All conceivable washing or cleaning processes can be enriched in at least one of the process steps by the use of a washing or cleaning agent according to the invention or a protease according to the invention and then represent embodiments of the present invention
  • Means are described are also applicable to this subject matter of the invention. For this reason, reference is expressly made at this point to the disclosure at the appropriate point with the note that this disclosure also applies to the above methods according to the invention.
  • proteases according to the invention already naturally have a hydrolytic activity and also develop this in media that otherwise have no cleaning power, such as, for example, in mere buffers, a single and / or the only step of such a method can consist in the fact that the only active cleaning component is a protease according to the invention is brought into contact with the soil, preferably in a buffer solution or in water. This represents a further embodiment of this subject matter of the invention.
  • Alternative embodiments of this subject matter of the invention also represent processes for treating raw textile materials or for textile care, in which a protease according to the invention becomes active in at least one process step.
  • processes for raw textile materials, fibers or textiles with natural components are preferred, and very particularly for those with wool or silk.
  • the invention also covers the use of the proteases described herein in washing or cleaning agents, for example as described above, for the (improved) removal of protein-containing soiling, for example from textiles or hard surfaces.
  • the protease is in the washing or detergents stored for 3 or more days, 4 or more days, 7 or more days, 10 or more days, 12 or more days, 14 or more days, 21 or more days or 28 or more days before a washing or cleaning process.
  • This invention relates to a subtilisin type alkaline protease from Bacillus pumilus. Variants of this protease (wild type Bacillus pumilus DSM18097 protease according to SEQ ID NO: 1) were produced by random mutagenesis, which were then screened for improved washing performance and / or enzyme stability, among other things. In this way, a mutant (COC [SEQ ID NO: 2]) improved in performance and stability was generated from the above-mentioned wild type protease (SEQ ID NO: 1) in several rounds by random mutagenesis. Further rounds of random mutagenesis were set up on this mutant. In these mutation rounds the mutants C1-C7 were generated. Therefore, all of the mutants mentioned here also carry the mutations of the mutant COC.
  • the following table shows the detergent matrix (commercially available, without enzymes, optical brighteners, perfume and dyes) that was used for the washing test:
  • the activity of the protease is determined by the release of the chromophore para-nitroaniline from the substrate succinyl alanine-alanine-proline-phenylalanine-para-nitroanilide (AAPFpNA; Bachem L-1400).
  • AAPFpNA succinyl alanine-alanine-proline-phenylalanine-para-nitroanilide
  • the measurement was carried out at a temperature of 25 ° C, at pH 8.6 and a wavelength of 410 nm.
  • the measurement time was 5 minutes with a measurement interval of 20 to 60 seconds.
  • proteases were stirred into a detergent matrix (see above) at the same activity level and stored at 30 ° C. Using a customary activity assay for proteases (hydrolysis of suc-AAPF-pNA), the initial activity and the residual activity of the protease are measured after storage at 30 ° C. for 4 weeks. In order to generate harsh conditions, the proteases were stored in a detergent matrix without a stabilizer.
  • proteases were generated in shake flask supernatants from Bacillus subtilis. They were diluted to the same level of activity. 50% of the detergent matrix without boric acid was mixed with 50% appropriately diluted Bacillus subtilis protease supernatant and mixed thoroughly. The sealed jars were incubated at 30 ° C. At the time of sampling, a previously determined amount of matrix / protease mixture was removed and dissolved for 20 min at RT in the sample buffer (0.1 M Tris / HCl, pH 8.6) by stirring. The AAPF assay is then performed as described above.
  • the claimed mutants have been found to be advantageous.
  • the activity is shown in% of the residual activity of the starting variant (mutant 1 according to SEQ ID NO: 2) - which already has a significantly improved stability compared to the wild-type enzyme - after storage at 30 ° C. for 4 weeks.

Abstract

L'invention concerne des protéases comprenant une séquence d'acides aminés partageant au moins 70 % d'identité de séquence avec la séquence d'acides aminés de SEQ ID NO : 1, sur toute leur longueur, et, par rapport à la numérotation selon SEQ ID NO : 1 (a) présente des substitutions d'acides aminés 9T, 130D/V, 133A, 144K, 217M, 252T et 271E à des positions correspondant aux positions 9, 130, 133, 144, 217, 252 et 271 ; et (b) présente au moins une substitution d'acide aminé supplémentaire à l'une des positions correspondant aux positions 6, 89, 131, 166, 189, 211 ou 224. L'invention concerne également la production et l'utilisation desdites protéases. Les protéases de ce type présentent une très bonne stabilité avec de bonnes performances de nettoyage.
EP21708957.2A 2020-03-03 2021-02-25 Variants de protéase vi à stabilité améliorée Pending EP4114934A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102020105720.2A DE102020105720A1 (de) 2020-03-03 2020-03-03 Stabilitätsverbesserte Proteasevarianten VI
PCT/EP2021/054688 WO2021175696A1 (fr) 2020-03-03 2021-02-25 Variants de protéase vi à stabilité améliorée

Publications (1)

Publication Number Publication Date
EP4114934A1 true EP4114934A1 (fr) 2023-01-11

Family

ID=74844885

Family Applications (1)

Application Number Title Priority Date Filing Date
EP21708957.2A Pending EP4114934A1 (fr) 2020-03-03 2021-02-25 Variants de protéase vi à stabilité améliorée

Country Status (6)

Country Link
US (1) US20230159908A1 (fr)
EP (1) EP4114934A1 (fr)
KR (1) KR20220148186A (fr)
CN (1) CN115427563A (fr)
DE (1) DE102020105720A1 (fr)
WO (1) WO2021175696A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023225459A2 (fr) 2022-05-14 2023-11-23 Novozymes A/S Compositions et procédés de prévention, de traitement, de suppression et/ou d'élimination d'infestations et d'infections phytopathogènes
DE102022205591A1 (de) 2022-06-01 2023-12-07 Henkel Ag & Co. Kgaa Wasch- und reinigungsmittel mit verbesserter enzymstabilität
DE102022205588A1 (de) 2022-06-01 2023-12-07 Henkel Ag & Co. Kgaa Wasch- und reinigungsmittel mit verbesserter enzymstabilität
DE102022205593A1 (de) 2022-06-01 2023-12-07 Henkel Ag & Co. Kgaa Wasch- und reinigungsmittel mit verbesserter enzymstabilität
DE102022205594A1 (de) 2022-06-01 2023-12-07 Henkel Ag & Co. Kgaa Leistungsverbesserte und lagerstabile protease-varianten
DE102022208891A1 (de) 2022-08-16 2024-02-22 Henkel Ag & Co. Kgaa Leistungsverbesserte protease-varianten x
DE102022208890A1 (de) 2022-08-16 2024-02-22 Henkel Ag & Co. Kgaa Leistungsverbesserte protease-varianten ix
WO2024037685A1 (fr) 2022-08-16 2024-02-22 Henkel Ag & Co. Kgaa Variants ix de protéase à performance améliorée
WO2024037686A1 (fr) 2022-08-16 2024-02-22 Henkel Ag & Co. Kgaa Variants x de protéase à performance améliorée
EP4324900A1 (fr) 2022-08-17 2024-02-21 Henkel AG & Co. KGaA Composition détergente comprenant des enzymes
WO2024050343A1 (fr) 2022-09-02 2024-03-07 Danisco Us Inc. Variants de subtilisine et procédés associés
DE102022209245A1 (de) 2022-09-06 2024-03-07 Henkel Ag & Co. Kgaa Wasch- und reinigungsmittel enthaltend tannase i
DE102022209246A1 (de) 2022-09-06 2024-03-07 Henkel Ag & Co. Kgaa Wasch- und reinigungsmittel enthaltend tannase ii

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102006022224A1 (de) 2006-05-11 2007-11-15 Henkel Kgaa Subtilisin aus Bacillus pumilus und Wasch- und Reinigungsmittel enthaltend dieses neue Subtilisin
DE102008017103A1 (de) 2008-04-02 2009-10-08 Henkel Ag & Co. Kgaa Wasch- und Reinigungsmittel enthaltend Proteasen aus Xanthomonas
US11421213B2 (en) * 2017-09-05 2022-08-23 Henkel Ag & Co. Kgaa Performance-enhanced protease variants II
DE102018208778A1 (de) 2018-06-05 2019-12-05 Henkel Ag & Co. Kgaa Leistungsverbesserte Proteasevarianten IV
WO2019048495A1 (fr) * 2017-09-05 2019-03-14 Henkel Ag & Co. Kgaa Variantes de protéases à performances améliorées
DE102019111057A1 (de) 2019-04-29 2020-10-29 Henkel Ag & Co. Kgaa Proteasen mit verbesserter Enzymstabilität in Wasch- und Reinigungsmitteln III

Also Published As

Publication number Publication date
DE102020105720A1 (de) 2021-09-09
WO2021175696A1 (fr) 2021-09-10
US20230159908A1 (en) 2023-05-25
CN115427563A (zh) 2022-12-02
KR20220148186A (ko) 2022-11-04

Similar Documents

Publication Publication Date Title
EP4114934A1 (fr) Variants de protéase vi à stabilité améliorée
EP4114933A1 (fr) Variantes de protéase à performance améliorée vii
EP3963065A1 (fr) Protéases présentant une stabilité enzymatique améliorée dans des détergents et produits de nettoyage iii
EP3660151B1 (fr) Variants de protéases présentant une performance ameliorée et stabilité au stockage
WO2020221578A1 (fr) Performance de nettoyage améliorée contre des salissures vi sensibles aux protéines
EP3963066A1 (fr) Performance de nettoyage améliorée contre des salissures v sensibles à des protéines
EP3679133A1 (fr) Variantes de protéases à performances améliorées
EP3679131A1 (fr) Variantes de protéases à performances améliorées
EP3433360B1 (fr) Protéases présentant une meilleure stabilité enzymatique dans les détergents
EP3679132B1 (fr) Variantes de protéase à performances améliorées
EP3660146B1 (fr) Variantes de prothèse stables au stockage et à la performance améliorée
EP3458583B1 (fr) Protéases à performances améliorées
EP3433359B1 (fr) Performance de nettoyage améliorée sur des salissures sensibles aux protéines
DE102018208778A1 (de) Leistungsverbesserte Proteasevarianten IV
DE102018004207A1 (de) Leistungsverbesserte Varianten der alkalischen Protease aus B. lentus
EP3440203B1 (fr) Nouvelle protéase à performance de lavage améliorée
DE102021207704A1 (de) Leistungsverbesserte Proteasevarianten VIII
DE102018208777A1 (de) Leistungsverbesserte Proteasevarianten V
DE102017215631A1 (de) Leistungsverbesserte Proteasevarianten II
DE102017215628A1 (de) Leistungsverbesserte Proteasevarianten I
DE102012220101A1 (de) Leistungsverbesserte Proteasevarianten
EP3083955A1 (fr) Protéases fongiques et leur utilisation dans des produits de lavage et de nettoyage

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20220805

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
P01 Opt-out of the competence of the unified patent court (upc) registered

Effective date: 20230530